152 related articles for article (PubMed ID: 26802654)
1. Apoptotic Melanoma B16-F1 Cells Induced by Lidamycin Could Initiate the Antitumor Immune Response in BABL/c Mice.
Yang JL; Qin Y; Li L; Cao CY; Wang Q; Li Q; Lv YF; Wang Y
Oncol Res; 2016 Jan; 23(1-2):79-86. PubMed ID: 26802654
[TBL] [Abstract][Full Text] [Related]
2. Melanoma B16-F1 cells coated with fusion protein of mouse calreticulin and virus G-protein coupled receptor induced the antitumor immune response in Balb/C mice.
Qin Y; Han Y; Cao C; Ren Y; Li C; Wang Y
Cancer Biol Ther; 2011 Mar; 11(6):574-80. PubMed ID: 21270533
[TBL] [Abstract][Full Text] [Related]
3. Enediyne lidamycin induces apoptosis in human multiple myeloma cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
Zhen YZ; Lin YJ; Shang BY; Zhen YS
Int J Hematol; 2009 Jul; 90(1):44-51. PubMed ID: 19468799
[TBL] [Abstract][Full Text] [Related]
4. Mitoxantrone-mediated apoptotic B16-F1 cells induce specific anti-tumor immune response.
Cao C; Han Y; Ren Y; Wang Y
Cell Mol Immunol; 2009 Dec; 6(6):469-75. PubMed ID: 20003823
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the antitumor activities of immunoconjugates composed of lidamycin and monoclonal antibody fab' fragment with different linkers].
Feng Y; Shao RG; Dai Y; Li BW; He HW; Ren KH
Yao Xue Xue Bao; 2010 May; 45(5):571-5. PubMed ID: 20931757
[TBL] [Abstract][Full Text] [Related]
6. Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice.
Zhen YZ; Lin YJ; Li Y; Zhen YS
Acta Pharmacol Sin; 2009 Jul; 30(7):1025-32. PubMed ID: 19575006
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
8. [Lidamycin induces apoptosis of human gastric carcinoma BGC823 cells and inhibits xenograft growth in nude mice].
Zhang SH; Chen J; Jiang M; Zhen YS
Yao Xue Xue Bao; 2008 Jun; 43(6):601-4. PubMed ID: 18822962
[TBL] [Abstract][Full Text] [Related]
9. Hsp90 inhibitor geldanamycin enhances the antitumor efficacy of enediyne lidamycin in association with reduced DNA damage repair.
Han FF; Li L; Shang BY; Shao RG; Zhen YS
Asian Pac J Cancer Prev; 2014; 15(17):7043-8. PubMed ID: 25227788
[TBL] [Abstract][Full Text] [Related]
10. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
[TBL] [Abstract][Full Text] [Related]
11. [Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Shang BY; Shang Y; Zhen YS; Chen SZ
Yao Xue Xue Bao; 2011 Nov; 46(11):1321-5. PubMed ID: 22260022
[TBL] [Abstract][Full Text] [Related]
12. Non-caspase-mediated apoptosis contributes to the potent cytotoxicity of the enediyne antibiotic lidamycin toward human tumor cells.
Wang Z; He Q; Liang Y; Wang D; Li YY; Li D
Biochem Pharmacol; 2003 Jun; 65(11):1767-75. PubMed ID: 12781328
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
Liu XY; Zhen YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activities of dFv-LDP-AE: An enediyne-energized fusion protein targeting tumor-associated antigen gelatinases.
Zhong GS; Wu MN; Guo XF; Zhang SH; Miao QF; Zhen YS
Oncol Rep; 2012 Oct; 28(4):1193-9. PubMed ID: 22797730
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract][Full Text] [Related]
16. Whole-cell vaccine coated with recombinant calreticulin enhances activation of dendritic cells and induces tumour-specific immune responses.
Wu H; Han Y; Qin Y; Cao C; Xia Y; Liu C; Wang Y
Oncol Rep; 2013 Feb; 29(2):529-34. PubMed ID: 23166014
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma.
Li L; Huang YH; Li Y; Wang FQ; Shang BY; Zhen YS
World J Gastroenterol; 2005 Aug; 11(29):4478-83. PubMed ID: 16052675
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.
Zhen HY; He QH; Zhen YZ; Wang SL; Liu YN; Wu WH; Zhang XY; Lu AL; Shen L
Invest New Drugs; 2011 Dec; 29(6):1188-97. PubMed ID: 20596749
[TBL] [Abstract][Full Text] [Related]
19. [The synergistic effect of lidamycin and rituximab on human B cell lymphoma].
Sun YR; Zhang SH; Shao RG; He HW
Yao Xue Xue Bao; 2014 Feb; 49(2):198-203. PubMed ID: 24761609
[TBL] [Abstract][Full Text] [Related]
20. P53 dependent and independent apoptosis induced by lidamycin in human colorectal cancer cells.
Chen L; Jiang J; Cheng C; Yang A; He Q; Li D; Wang Z
Cancer Biol Ther; 2007 Jun; 6(6):965-73. PubMed ID: 17534142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
